Jean-Baptiste Alberge, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 14 | 2024 | 5146 | 1.180 |
Why?
|
5-Methylcytosine | 1 | 2020 | 148 | 0.700 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 790 | 0.550 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 3 | 2024 | 179 | 0.530 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 2010 | 0.430 |
Why?
|
Genome | 1 | 2020 | 1740 | 0.410 |
Why?
|
Immunotherapy, Adoptive | 3 | 2024 | 1469 | 0.230 |
Why?
|
Cyclin D2 | 1 | 2020 | 98 | 0.180 |
Why?
|
Thiophenes | 1 | 2024 | 569 | 0.170 |
Why?
|
Paraproteinemias | 1 | 2022 | 248 | 0.160 |
Why?
|
Cyclin D1 | 1 | 2020 | 451 | 0.160 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2024 | 1349 | 0.150 |
Why?
|
Neoplasm, Residual | 1 | 2022 | 1008 | 0.140 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 682 | 0.130 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2023 | 946 | 0.130 |
Why?
|
Dexamethasone | 1 | 2023 | 1948 | 0.130 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2200 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2020 | 988 | 0.120 |
Why?
|
Lymphoma | 1 | 2024 | 1901 | 0.120 |
Why?
|
Epigenomics | 1 | 2020 | 943 | 0.120 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1784 | 0.100 |
Why?
|
Radiopharmaceuticals | 1 | 2022 | 2651 | 0.100 |
Why?
|
Pyrimidines | 1 | 2024 | 3028 | 0.100 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3802 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2024 | 13639 | 0.090 |
Why?
|
Plasma Cells | 2 | 2024 | 599 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2020 | 2986 | 0.080 |
Why?
|
Chromatin | 1 | 2020 | 2960 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2024 | 1405 | 0.070 |
Why?
|
DNA Methylation | 1 | 2020 | 4398 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9420 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8547 | 0.060 |
Why?
|
bcl-2-Associated X Protein | 1 | 2024 | 282 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16591 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15842 | 0.050 |
Why?
|
Bone Marrow | 2 | 2023 | 2911 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16981 | 0.050 |
Why?
|
Antibodies, Bispecific | 1 | 2024 | 196 | 0.050 |
Why?
|
Humans | 15 | 2024 | 761504 | 0.050 |
Why?
|
Receptors, Glucocorticoid | 1 | 2023 | 305 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5709 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2024 | 1351 | 0.050 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3877 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2024 | 1359 | 0.040 |
Why?
|
Apoptosis | 2 | 2024 | 9486 | 0.040 |
Why?
|
Disease Progression | 2 | 2024 | 13506 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1827 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2418 | 0.030 |
Why?
|
Random Allocation | 1 | 2020 | 2395 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9280 | 0.030 |
Why?
|
Biological Products | 1 | 2024 | 914 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2022 | 2192 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2023 | 2020 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2626 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2023 | 2161 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 2917 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2022 | 2825 | 0.030 |
Why?
|
Transfection | 1 | 2020 | 5774 | 0.020 |
Why?
|
Base Sequence | 1 | 2023 | 12441 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3602 | 0.020 |
Why?
|
Cell Line | 1 | 2024 | 15601 | 0.020 |
Why?
|
Immunotherapy | 1 | 2023 | 4652 | 0.020 |
Why?
|
Female | 3 | 2022 | 392644 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10194 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2023 | 7856 | 0.020 |
Why?
|
Middle Aged | 1 | 2020 | 220895 | 0.020 |
Why?
|
Male | 2 | 2022 | 360804 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15732 | 0.020 |
Why?
|
Obesity | 1 | 2024 | 12947 | 0.010 |
Why?
|
Animals | 2 | 2024 | 168459 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41487 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 74206 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81525 | 0.010 |
Why?
|